Anya Biopharm (7776.TWO) Stock Price

Anya Biopharm Price

CLOSED
30.00
​
Market closed

Over the last 2 years Anya Biopharm grew revenue by 194.1% annually, reaching 21.60 M TWD. For Anya Biopharm, the net margin of -171.1% is up versus -1,675.9% a few years ago.

Anya Biopharm stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Anya Biopharm business model & stock analysis

Anya Biopharm Inc generates revenue by researching and developing oral peptide dosage form platforms and new drug products within the pharmaceuticals industry. The company leverages its MIRA/JE oral peptide formulation platform to create lead products, most notably ANY002, which is a glucagon-like peptide-1 (GLP-1) receptor agonist designed for the treatment of type 2 diabetes and obesity. This core asset has advanced through early clinical pharmacokinetic trials in both animals and humans, establishing the company's value proposition in the biotech sector. The firm also markets its proprietary oral dosage form technology through the development of ANY004, which is currently in preclinical development. By focusing on these specific drug projects and formulation platforms, Anya Biopharm Inc targets the professional biotech and pharmaceutical business segments. The company operates from its headquarters in Taipei City, Taipei, and serves the global market for innovative diabetes and obesity treatments through its specialized research and development capabilities.

Frequently asked questions about Anya Biopharm

Converted at the current exchange rate, the Anya Biopharm share trades at 0.82 EUR (30.00 TWD).

The revenue cannot currently be calculated for Anya Biopharm.

The profit cannot currently be calculated for Anya Biopharm.

The P/E ratio cannot be calculated for Anya Biopharm at the moment.

The P/S cannot be calculated for Anya Biopharm currently.

The Eulerpool Quality Score for Anya Biopharm is 1/10.

The ISIN of Anya Biopharm is TW0007776007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Anya Biopharm is 7776.TWO. The ticker symbol is used to trade Anya Biopharm shares on the stock exchange.

Fair ValueTerminal
27.90 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Oct 25, 2024
ISIN
TW0007776007
Cusip
Y0162M108
Market capitalization
1.47 B TWDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
3.15
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-7.86 %
Last updated Nov 4, 2026, 3:48 AM

Anya Biopharm Peer Group